Ainos, Inc. (NASDAQ:AIMD) Short Interest Update

Ainos, Inc. (NASDAQ:AIMD) saw a large decrease in short interest during the month of June. As of June 15th, there was short interest totaling 18,552 shares, a decrease of 79.8% from the May 31st total of 91,823 shares. Currently, 0.2% of the shares of the company are short sold. Based on an average daily trading volume, of 66,646 shares, the days-to-cover ratio is currently 0.3 days.

Insiders Place Their Bets

In other news, Director Ting-Chuan Lee sold 109,988 shares of Ainos stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $1.90, for a total value of $208,977.20. Following the sale, the director owned 807,417 shares of the company’s stock, valued at $1,534,092.30. The trade was a 11.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder Carbon Nano Technology Taiwan sold 41,000 shares of Ainos stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $2.36, for a total transaction of $96,760.00. Following the completion of the sale, the insider directly owned 948,925 shares in the company, valued at approximately $2,239,463. The trade was a 4.14% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders bought 7,800 shares of company stock worth $15,946 and sold 179,788 shares worth $359,247. 9.79% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in AIMD. DRW Securities LLC increased its holdings in Ainos by 272.6% in the fourth quarter. DRW Securities LLC now owns 66,211 shares of the company’s stock valued at $109,000 after buying an additional 48,439 shares in the last quarter. Renaissance Technologies LLC lifted its position in shares of Ainos by 13.1% during the 4th quarter. Renaissance Technologies LLC now owns 66,300 shares of the company’s stock valued at $109,000 after acquiring an additional 7,700 shares during the period. Two Sigma Investments LP purchased a new stake in shares of Ainos during the 3rd quarter worth approximately $80,000. Finally, Mariner LLC purchased a new stake in shares of Ainos during the 4th quarter worth approximately $37,000.

Ainos Price Performance

Ainos stock opened at $1.73 on Friday. The company has a market cap of $14.74 million, a P/E ratio of -0.60 and a beta of 2.41. Ainos has a one year low of $1.26 and a one year high of $4.50. The business has a fifty day moving average of $1.90 and a two-hundred day moving average of $1.79. The company has a debt-to-equity ratio of 1.58, a quick ratio of 0.50 and a current ratio of 0.55.

Ainos (NASDAQ:AIMD) last posted its quarterly earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share for the quarter. Ainos had a negative return on equity of 160.55% and a negative net margin of 11,912.10%.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded shares of Ainos from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, May 26th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of “Sell”.

Ainos Company Profile

Ainos, Inc (NASDAQ: AIMD) is a clinical?stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI?401, is an inhaled formulation of ibuprofen in a dry powder format.